Leiner revising cold, menstrual pain, motion sickness claims in response to FDA concerns.
This article was originally published in The Tan Sheet
Executive Summary
LEINER REVISING COLD, MENSTRUAL PAIN, MOTION SICKNESS CLAIMS for three dietary supplement products after receiving recent notification from FDA that the statements, which already had been modified once, still constitute drug claims. Leiner plans to change the claims to more closely adhere to the Dietary Supplement Health & Education Act; the amended labeling will appear on the products Your Life Echinacea and Goldenseal, Your Life Dong Quai and Your Life Ginger in 1997.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning